Axplora Overview

  • Year Founded
  • 1946

Year Founded

  • Status
  • Private

  • Employees
  • 900

Employees

  • Latest Deal Type
  • Debt - Acquisition

  • Financing Rounds
  • 9

  • Investments
  • 4

Axplora General Information

Description

Developer of active pharmaceutical ingredients (API) and natural source materials intended for blue-chip pharmaceutical companies. The company offers a focused portfolio of small molecule APIs combined with custom development and manufacturing services for the generic and originator pharmaceutical industry.

Contact Information

Website
www.axplora.com
Formerly Known As
PharmaZell GmbH, ZellBios, PharmaZell
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Rosenheimer Street 43
  • 83064 Raubling
  • Germany
+49 08035
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Discovery Tools (Healthcare)
Corporate Office
  • Rosenheimer Street 43
  • 83064 Raubling
  • Germany
+49 08035

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axplora Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axplora‘s full profile, request access.

Request a free trial

Axplora Patents

  • 108

    Total Documents Applications and Grants

  • Total Patents Families

  • 57

    Granted

  • 12

    Pending

  • Expiring in next 12 mo

Axplora Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4504996-A1 Method for preparing periodates via anodic oxidation in a steady state reactor Pending 05-Apr-2022
US-20230159452-A1 Regioselective oxidation of heterocyclic alpha-amino amides Pending 24-Apr-2020
EP-4139468-A1 Enantioselective chemo-enzymatic synthesis of optically active amino amide compounds Pending 24-Apr-2020
EP-4139283-A2 Regioselective oxidation of heterocyclic alpha-amino amides Pending 24-Apr-2020
US-20230183177-A1 Enantioselective chemo-enzymatic synthesis of optically active amino amide compounds Pending 24-Apr-2020 C07D207/27
To view Axplora’s complete patent history, request access »

Axplora Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axplora Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Axplora‘s full profile, request access.

Request a free trial

Axplora Investments (4)

Axplora’s most recent deal was a Buyout/LBO with Novasep Belgium. The deal was made on 01-Apr-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novasep Belgium 01-Apr-2022 Buyout/LBO BPO/Outsource Services
Axplora (Acquired) 16-Sep-2021 Buyout/LBO BPO/Outsource Services
Farmabios 18-Oct-2011 Buyout/LBO Biotechnology
GEA Pharmaceutical 12-Jul-2007 Buyout/LBO Pharmaceuticals
To view Axplora’s complete investments history, request access »

Axplora Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Axplora (Acquired) Raubling, Germany 1995

Axplora FAQs

  • When was Axplora founded?

    Axplora was founded in 1946.

  • Where is Axplora headquartered?

    Axplora is headquartered in Raubling, Germany.

  • What is the size of Axplora?

    Axplora has 900 total employees.

  • What industry is Axplora in?

    Axplora’s primary industry is Pharmaceuticals.

  • Is Axplora a private or public company?

    Axplora is a Private company.

  • What is Axplora’s current revenue?

    The current revenue for Axplora is .

  • How much funding has Axplora raised over time?

    Axplora has raised $17.8M.

  • Who are Axplora’s investors?

    Bridgepoint Group (UK) and RAG-Stiftung have invested in Axplora.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »